Atomi Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Buy
1,811
+939
+108% +$348K 0.02% 630
2026
Q1
$255K Sell
872
-188
-18% -$61.8K 0.01% 1039
2025
Q4
$372K Buy
1,060
+176
+20% +$59.5K 0.01% 825
2025
Q3
$286K Buy
884
+128
+17% +$39.8K 0.01% 915
2025
Q2
$294K Sell
756
-422
-36% -$170K 0.01% 829
2025
Q1
$513K Buy
1,178
+521
+79% +$209K 0.02% 527
2024
Q4
$243K Buy
657
+42
+7% +$17.6K 0.01% 824
2024
Q3
$320K Buy
615
+25
+4% +$13.4K 0.02% 641
2024
Q2
$320K Buy
590
+43
+8% +$22.7K 0.02% 566
2024
Q1
$284K Sell
547
-4
-0.7% -$1.99K 0.03% 560
2023
Q4
$260K Buy
+551
New +$255K 0.04% 460

Other funds holding ELV

Atomi Financial Group's ELV Position: Q2 2026 in Review

Atomi Financial Group increased its Elevance Health (ELV) stake by 108% in Q2 2026, buying an estimated $348K and bringing the position to 1,811 shares worth $700K. The position accounts for 0.02% of the portfolio, ranked #630.

Atomi Financial Group first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Atomi Financial Group held 1,811 shares of Elevance Health worth $700K as of Q2 2026.
  • Atomi Financial Group bought 939 Elevance Health shares in Q2 2026, an estimated $348K.
  • Elevance Health made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #630 holding.
  • Atomi Financial Group first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.